- Home
- BWAY vs AMBI Comparison
BWAY vs AMBI Comparison
Compare BWAY & AMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- AMBI
- Stock Information
- Founded
- BWAY 2003
- AMBI 1995
- Country
- BWAY Israel
- AMBI Brazil
- Employees
- BWAY N/A
- AMBI N/A
- Industry
- BWAY Medical/Dental Instruments
- AMBI Environmental Services
- Sector
- BWAY Health Care
- AMBI Industrials
- Exchange
- BWAY Nasdaq
- AMBI Nasdaq
- Market Cap
- BWAY 280.7M
- AMBI 265.0M
- IPO Year
- BWAY 2019
- AMBI N/A
- Fundamental
- Price
- BWAY $15.77
- AMBI $4.70
- Analyst Decision
- BWAY Strong Buy
- AMBI
- Analyst Count
- BWAY 2
- AMBI 0
- Target Price
- BWAY $18.00
- AMBI N/A
- AVG Volume (30 Days)
- BWAY 78.9K
- AMBI 8.0K
- Earning Date
- BWAY 11-11-2025
- AMBI 01-01-0001
- Dividend Yield
- BWAY N/A
- AMBI N/A
- EPS Growth
- BWAY 515.14
- AMBI N/A
- EPS
- BWAY 0.11
- AMBI N/A
- Revenue
- BWAY $46,084,000.00
- AMBI $525,221,427.00
- Revenue This Year
- BWAY $339.49
- AMBI N/A
- Revenue Next Year
- BWAY $21.74
- AMBI N/A
- P/E Ratio
- BWAY $55.73
- AMBI N/A
- Revenue Growth
- BWAY 26.50
- AMBI 25.42
- 52 Week Low
- BWAY $7.70
- AMBI $3.70
- 52 Week High
- BWAY $16.25
- AMBI $8.20
- Technical
- Relative Strength Index (RSI)
- BWAY 67.06
- AMBI 49.89
- Support Level
- BWAY $15.32
- AMBI $4.50
- Resistance Level
- BWAY $16.25
- AMBI $5.06
- Average True Range (ATR)
- BWAY 0.59
- AMBI 0.17
- MACD
- BWAY -0.07
- AMBI -0.00
- Stochastic Oscillator
- BWAY 70.25
- AMBI 33.33
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.